RestorationMaster Backs Michael Clayton and City Garage Motorsports at Lucas Oil Indianapolis Raceway Park
Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets
MicroCloud Hologram Inc. Announces Acquisition of 140,268 MSTR Shares Through Structured Note Investment Product, Continuing Its Strategic Investment in Bitcoin-Related Assets
global
View All ->
Global Footwear Recycling Market to Reach $2.9 Billion by 2031 as Circularity and Regulation Reshape the Industry, Says BCC Research Analyst
“The global footwear recycling market is projected to grow from $1.5 billion in 2025 to $2.9 billion by 2031, at an 11.6% CAGR, driven by circularity pressure, rising footwear production and stricter waste regulations.” Boston, Aug. 21, 2026 (GLOBE NEWSWIRE) -- The global footwear recycling market is projected to grow from $1.5 billion in 2025 to $3.0 billion by 2031, advancing at a compound annual growth rate (CAGR) of 11.6% over the forecast period 2026–2031, according to BCC Research's latest
Global Data Center Investment Projected to Reach $3 Trillion By 2030
Issued on behalf of BOXABL Inc. LAS VEGAS, Aug. 21, 2026 (GLOBE NEWSWIRE) -- USA News Group News Commentary - The data center sector is entering what JLL Research has called one of the largest infrastructure investment supercycles in the modern era. According to JLL's 2026 Global Data Center Market Outlook, the sector is expected to grow at a 14% compound annual rate through 2030, with roughly 100 GW of new capacity coming online between 2026 and 2030, nearly doubling global capacity. Active Com
newsAI-Driven Modular Microfactories Emerge as a Global Manufacturing Frontier, Backed by Record Investment and Government Policy Mandates
“AI-driven microfactories gain momentum as private investment, industrial policy and automation accelerate decentralized manufacturing worldwide.” Boston, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Modular microfactories — compact, reconfigurable production systems increasingly powered by artificial intelligence — are undergoing a structural transformation driven by unprecedented private capital flows, national industrial policy mandates, and the convergence of agentic AI, edge computing, and robotics. B
Business Digest
newsHKC, KOORUI and ANTGAMER Invite Global Partners to IFA 2026 for an Immersive Vision of the Future
newsBL Networks (BLNWX) Details Major Global Infrastructure Expansion and Upgrades
newsAI Disruption Reshapes Global Investment Landscape as Agentic Systems, Sovereign Infrastructure, and Enterprise Integration Drive a New Era of Compute Demand
announces
View All ->Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets
REYKJAVIK, ICELAND (August 21, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced a strategic licensing and commercialization agreement with Lotus Pharmaceutical (TWSE Stock Code: 1795) covering two of Alvotech’s candidates in the United States and selected Asian markets: AVT34, a proposed biosimilar to Imfinzi® (durvalumab), and AVT87, a proposed biosimilar to H
MicroCloud Hologram Inc. Announces Acquisition of 140,268 MSTR Shares Through Structured Note Investment Product, Continuing Its Strategic Investment in Bitcoin-Related Assets
SHENZHEN, China, Aug. 21, 2026 (GLOBE NEWSWIRE) -- MicroCloud Hologram Inc. (NASDAQ: HOLO) (the “Company” or “HOLO”), a technology services provider, today announced that the Company has completed the acquisition of assets through a structured note investment product, obtaining an aggregate of 140,268 shares of MSTR common stock . Based on MSTR’s closing price on the previous trading day, the market value of these shares was approximately $15.76 million . The acquisition of the shares resulted f
newsGDEV announces results for the second quarter and first half of 2026
LIMASSOL, Cyprus, Aug. 21, 2026 (GLOBE NEWSWIRE) -- GDEV Inc. (NASDAQ: GDEV), an international gaming and entertainment company (“GDEV” or the “Company”) released its unaudited financial and operational results for the second quarter and first half-year ended June 30, 2026. Second quarter 2026 financial highlights: Revenue of $94 million decreased by 22% year-over-year. Selling and marketing expenses of $33 million decreased by 38% year-over-year. Profit for the period, net of tax, of $20 millio
Business Digest
newsBrandywine Realty Trust Announces Upsize and Extension of Expiration of the Previously Announced Tender Offer for the 2029 Notes
newsArbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer
newsSynaptics Announces Chief Financial Officer Transition
india
View All ->RestorationMaster Backs Michael Clayton and City Garage Motorsports at Lucas Oil Indianapolis Raceway Park
The RestorationMaster logo rode on the No. 5 Ford as CGM co-owner Michael Clayton made his ARCA Menards Series East debut at one of the sport's most historic short tracks. Tampa, FL, Aug. 21, 2026 (GLOBE NEWSWIRE) -- RestorationMaster , a 24/7 disaster restoration and cleaning company serving homes and businesses across the Tampa Bay area, backed City Garage Motorsports (CGM) for the ARCA Menards Series' stop at Lucas Oil Indianapolis Raceway Park, with its logo featured on the No. 5 Ford driven
Sprite and IRCTC Flag Off India's First Branded Train as the Sprite Tejas Express
The Sprite Tejas Express will operate on the Lucknow New Delhi Lucknow route, bringing Sprite s signature refreshment and experiences to Indian travellers. NEW DELHI , Aug. 21, 2026 -- Rail travel has long been an integral part of India s mobility and social fabric, connecting cities, communities, and millions of passengers across the country. In a first-of-its-kind partnership, Sprite and the Indian Railway Catering and Tourism Corporation (IRCTC) today flagged off the Sprite Tejas Express, in the presence of senior leadership from Indian Railways, IRCTC and Coca-Cola India. Bringing together Sprite s signature refreshment with India s diverse travel culture, the partnership creates a new experience for passengers travelling between the two cities, where varied tastes, preferences and shared moments come together along the journey.
newsColgate-Palmolive elevates Prabha Narasimhan to EVP - Marketing, Asia-Pacific and announces Manish Anandani as new MD & CEO for India
MUMBAI, India , Aug. 21, 2026 -- Colgate-Palmolive India Limited today announced a key leadership transition. Prabha Narasimhan, Managing Director and Chief Executive O cer, has been elevated to the role of Executive Vice President Marketing, Asia-Pacific Division, Colgate-Palmolive, effective close of business hours on 27 September, 2026. To lead the company into its next growth phase, the Board of Directors has approved the appointment of Manish Anandani as Managing Director and Chief Executive O cer, effective 28 September, 2026.
million
View All ->
Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 million Private Placement
Proposed merger to create a Nasdaq-listed, late-stage biotechnology company advancing neridronate, a potential first FDA-approved treatment for CRPS-1, a debilitating orphan disease with 65,000 newly diagnosed U.S. patients annually and no currently FDA-approved therapy Pivotal CRPS-RISE Phase 3 trial evaluating neridronate remains ongoing, with FDA Breakthrough Therapy, Fast Track and Orphan Drug designations received and alignment with FDA that a single successful pivotal trial could potential
Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 Million Private Placement
Proposed merger to create a Nasdaq-listed, late-stage biotechnology company advancing neridronate, a potential first FDA-approved treatment for CRPS-1, a debilitating orphan disease with 65,000 newly diagnosed U.S. patients annually and no currently FDA-approved therapy Pivotal CRPS-RISE Phase 3 trial evaluating neridronate remains ongoing, with FDA Breakthrough Therapy, Fast Track and Orphan Drug designations received and alignment with FDA that a single successful pivotal trial could potential
newsArbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer
WARMINSTER, Pa., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced plans to commence a modified “Dutch Auction” tender offer (the “Offer”) to repurchase up to US$230 million of its common shares at a purchase price of not less than US$5.00 per share and not more than US$5.75 per share, in cash, less any applicable withholding taxes and without inter
Business Digest
newsRecord FY26 Net Profit After Tax of A$228.7 Million (up 590%)
newsBrookfield Renewable to Issue C$750 Million of Green Bonds
newsOsisko Gold Announces Amendment to US$450 Million Appian Credit Facility and Satisfaction of Key Technical Conditions Precedent Following Successful Completion of the Lowhee Infill Drill Program at the Cariboo Gold Project
form
View All ->
Form 8.3 -DCC plc
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE KEY INFORM A TION Name of person dealing (Note 1) State Street Global Advisors & Affiliates Company dealt in DCC plc Class of relevant security to which the dealings being disclosed relate (Note 2) €0.25 ordinary shares Date of dealing 20 th August 2026 2. INTERESTS AND SHORT POSITIONS (110) Interests
Form 8.3 - Gooch & Housego plc - Octopus Investments
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: OCTOPUS INVESTMENTS LTD (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree
newsForm 8.3 - Advanced Medical Solutions Group plc - Octopus Investments
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: OCTOPUS INVESTMENTS LTD (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree